UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology

Animals (Basel), 2022-10, Vol.12 (19), p.2661

2022

Volltextzugriff (PDF)

Mukundrai Kris Jasani

BMJ (Online), 2024-07, p.q1675

Jasani, Bharat

2024

Volltextzugriff (PDF)

Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms

Modern pathology, 2018-11, Vol.31 (11), p.1630-1644

2018

Volltextzugriff (PDF)

Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

Histopathology, 2018-02, Vol.72 (3), p.449-459

2018

Volltextzugriff (PDF)

Precision Cancer Medicine: Role of the Pathologist

1, 2022

Volltextzugriff (PDF)

Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma

Frontiers in oncology, 2023-11, Vol.13, p.1252700-1252700

2023

Volltextzugriff (PDF)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

Journal of translational medicine, 2015-07, Vol.13 (1), p.217-217, Article 217

2015

Volltextzugriff (PDF)

A Review on Mammary Tumors in Rabbits: Translation of Pathology into Medical Care

Animals (Basel), 2019-10, Vol.9 (10), p.762

2019

Volltextzugriff (PDF)

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

Diagnostic pathology, 2020-04, Vol.15 (1), p.37-37, Article 37

2020

Volltextzugriff (PDF)

Tumor Infiltrating Lymphocytes in Pet Rabbit Mammary Carcinomas: A Study with Relevance to Comparative Pathology

Animals (Basel), 2020-08, Vol.10 (8), p.1437

2020

Volltextzugriff (PDF)

Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer

Diagnostic pathology, 2018-03, Vol.13 (1), p.19-19, Article 19

2018

Volltextzugriff (PDF)

Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?

Leukemia research, 2013-06, Vol.37 (6), p.607-608

2013

Volltextzugriff (PDF)

Mesothelioma not associated with asbestos exposure

Archives of pathology & laboratory medicine (1976), 2012-03, Vol.136 (3), p.262-267

2012

Volltextzugriff (PDF)

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors)

Human pathology, 2009-12, Vol.40 (12), p.1706-1714

2009

Volltextzugriff (PDF)

Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma

International journal of colorectal disease, 2009-11, Vol.24 (11), p.1287-1296

2009

Volltextzugriff (PDF)

Human wound contraction: collagen organization, fibroblasts, and myofibroblasts

Plastic and reconstructive surgery (1963), 1998-07, Vol.102 (1), p.124-131

1998

Volltextzugriff (PDF)

Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit

Gastroenterology (New York, N.Y. 1943), 2001-08, Vol.121 (2), p.350-357

2001

Volltextzugriff (PDF)

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status

Virchows Archiv : an international journal of pathology, 2022-11, Vol.481 (5), p.685-694

2022

Volltextzugriff (PDF)

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Biomarkers in Cancer, 2013-08, Vol.2013 (5), p.31-39

2013

Volltextzugriff (PDF)

Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin 18 Antibodies for Evaluation in Gastric Cancer

Laboratory investigation, 2024-01, Vol.104 (1), p.100284-100284, Article 100284

2024

Volltextzugriff (PDF)

High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications

Histopathology, 2022-12, Vol.81 (6), p.732-741

2022

Volltextzugriff (PDF)

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

American journal of clinical pathology, 2002, Vol.117 (1), p.81-89

2002

Volltextzugriff (PDF)

High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma

Modern pathology, 2023-05, Vol.36 (5), p.100154-100154, Article 100154

2023

Volltextzugriff (PDF)

Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data

Modern pathology, 2015-12, Vol.28 (12), p.1528-1534

2015

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(136)
Buchkapitel
(34)
Reviews
(2)
Bücher
(1)

Sprache

Englisch
(171)
Deutsch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(100)
Humans
(80)
Pathology
(53)
Biological And Medical Sciences
(51)
Immunohistochemistry
(43)
Medical Sciences
(40)
Female
(39)
Oncology
(29)
Tumors
(26)
Male
(24)
Animals
(19)
Adult
(16)
Investigative Techniques, Diagnostic Techniques
(15)
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous Investigative Techniques
(15)
Cell Biology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Metallothionein
(13)
Aged
(12)
Medicine
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology

Mukundrai Kris Jasani

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms

Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

Precision Cancer Medicine: Role of the Pathologist

Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

A Review on Mammary Tumors in Rabbits: Translation of Pathology into Medical Care

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

Tumor Infiltrating Lymphocytes in Pet Rabbit Mammary Carcinomas: A Study with Relevance to Comparative Pathology

Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer

Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?

Mesothelioma not associated with asbestos exposure

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors)

Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma

Human wound contraction: collagen organization, fibroblasts, and myofibroblasts

Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin 18 Antibodies for Evaluation in Gastric Cancer

High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma

Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data

Suchergebnisse filtern